August Debouzy

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Firms: prosecution

Recommended - Firms: transactions

Gold - Firms: litigation

Home to one of the foremost patent litigation divisions in France, August Debouzy has also cultivated a small but perfectly formed prosecution offering. Heavyweight players which have recently benefited from its robust representation in high-stakes proceedings include Teva, in a complex cross-border patent infringement matter against Novartis; agricultural machinery manufacturer Pellenc, in parallel infringement and nullity proceedings; and L’Oréal and Fapagau, in a packaging-related patent and trade secret dispute. The star names are litigators Grégoire Desrousseaux and François Pochart – both dual-qualified European patent attorneys and lawyers with a bird’s-eye view of each instruction. “Grégoire is by far one of the best lawyers we have ever encountered across a period of several decades,” reports one source. “He has excellent pleading skills and a high level of IP expertise, which is highly recognised beyond his own company. He combines incredible knowledge of clients’ businesses with a practical approach and an in-depth understanding of not only the French legal environment, but also the European patent system. His technical background and his unique ability to interact efficiently with the different national teams in cross-border cases complete an outstanding professional profile.” Pochart is likewise hailed by one patron as “the smartest and best IP practitioner I have worked with”: “François can envisage and manifest the best business outcome for the client, and has a Zen-like ability to ditch weaker arguments in favour of those strongest and most likely to succeed. His scientific background, knowledge of European patent procedure and familiarity with French law make him an excellent advocate in oppositions and appeals, and in the courts. He is quick on his feet, experienced in the pharmaceutical area and, most importantly, rigorous and infectiously enthusiastic.”

Get unlimited access to all IAM content